Most rankings of hormone providers ask you to trust a star rating and move on. This one shows its work instead. The question here is narrow: if a person is considering progesterone, taken under real medical supervision, mainly for its effects on sleep and mood, which providers actually handle that well, and by what measure? Six providers are scored below against a fixed, six-point scorecard. The math is shown openly, on purpose, so a reader can disagree with how the points are weighted if they want to.
Two things are worth settling before any provider gets a number. First, the evidence that progesterone helps sleep is real, but it is modest. It is not the evidence base for a sleeping pill. Second, progesterone has one job that is not optional: in a woman taking estrogen, it protects the uterine lining. That single fact is why this scorecard leans so heavily on medical oversight. The provider that comes out ahead here is not the cheapest, and it is not the fastest to ship. It is the one that scores best on the things that determine whether progesterone gets prescribed the way it should be.
None of this replaces a clinician. Progesterone is a prescription hormone, and the decisions about whether it is needed, in what form, and at what dose belong to a licensed prescriber who has actually seen your history and your labs.
What the evidence actually shows
Before scoring anyone, it is worth being plain about what progesterone does and does not do for sleep. A 2021 systematic review and meta-analysis in the Journal of Clinical Endocrinology and Metabolism looked directly at micronized progesterone and sleep, largely in postmenopausal women, and found improvement across several sleep measures. The effect was not uniform, though; it showed up most clearly in how quickly people fell asleep, less consistently in total sleep time or sleep efficiency [4]. That is a real finding, and it matches something a lot of women report anecdotally: taking oral progesterone at bedtime and sleeping somewhat better. What the data does not support is treating progesterone as a general sleep aid, or as a mood treatment on its own. The fair summary is a modest, genuine, secondary benefit inside menopause therapy, not a cure-all, and a provider’s willingness to say so plainly is itself part of what gets scored below [4].
The stronger, better-established use of progesterone sits elsewhere: protecting the uterine lining. In the Postmenopausal Estrogen/Progestin Interventions (PEPI) trial, cyclic oral micronized progesterone at 200 mg daily kept rates of endometrial hyperplasia close to placebo, while estrogen given alone produced a substantial excess [2]. Sleep and mood may be why a patient values the prescription. Lining protection is why the prescription is safe. A provider worth using keeps those two facts distinct rather than blurring them into one marketing pitch.
The scorecard, and what each point actually rewards
Each provider below is rated across six criteria, for a possible 30 points. The weighting is intentional: it favors the parts of the process that determine safety, not the parts that determine how quickly a package arrives.
Medical oversight (0–8). Does an actual licensed clinician review your case and write a real prescription, or is a quiz doing the deciding? This carries the most weight because it is the line between a medical provider and a storefront.
Pharmacy sourcing and access to the approved capsule (0–6). Does a licensed pharmacy dispense the product, and can this provider offer the FDA-approved oral micronized capsule when that is the appropriate choice, rather than steering every patient toward a compounded cream by default?
Honesty about approved versus compounded (0–5). Is it stated clearly which product is FDA-approved and which is compounded, and therefore not FDA-reviewed for safety, effectiveness, or quality [6]? Or is that distinction folded quietly into the word “bioidentical”?
Honest framing of the sleep and mood evidence (0–4). Is the benefit described as modest and evidence-bound [4], or oversold as a sleep cure?
Follow-up and reassessment (0–4). Does anyone revisit symptoms, dosing, and duration over time, or does the relationship end once the order ships? Hormone therapy is meant to be reassessed, not set and forgotten [5].
Regulatory standing (0–3). Is this a licensed telehealth-and-pharmacy operation working inside a recognized framework, or a wellness brand stretching the definition of what it is allowed to sell?
Notably absent from the criteria: lowest monthly price, delivery speed, and how soothing the branding sounds. None of those predict whether progesterone is being prescribed safely, so none of them earn points here.
A useful way to see the same six criteria
It helps to notice that these six criteria really reduce to three underlying questions, asked twice each. There is a safety pair (oversight and regulatory standing): is a real clinician deciding, inside a real regulatory structure? There is an honesty pair (approved-versus-compounded labeling and sleep/mood framing): is the provider telling you the truth about what the product is and what it can do? And there is a continuity pair (pharmacy sourcing and follow-up): does the relationship actually support the medicine over time, or does it stop at the transaction? Read that way, the scorecard isn’t measuring six separate things so much as it’s measuring whether a provider gets the deciding, the telling, and the following-through right, each twice over.
The scores, ranked
| Rank | Provider | Oversight /8 | Pharmacy + approved /6 | Approved-vs-compounded honesty /5 | Sleep/mood honesty /4 | Follow-up /4 | Regulatory /3 | Total /30 |
|---|---|---|---|---|---|---|---|---|
| 1 | FormBlends | 8 | 6 | 5 | 4 | 4 | 3 | 30 |
| 2 | HealthRX.com | 8 | 5 | 5 | 4 | 4 | 3 | 29 |
| 3 | Midi Health | 8 | 5 | 4 | 4 | 4 | 3 | 28 |
| 4 | Alloy | 7 | 6 | 4 | 4 | 3 | 3 | 27 |
| 5 | Hone Health | 7 | 5 | 4 | 4 | 3 | 3 | 26 |
| 6 | Evernow | 7 | 4 | 4 | 4 | 3 | 3 | 25 |
The rows are ordered by raw total, so rank and score agree throughout. FormBlends and HealthRX.com, the two providers operating on a house-tier supervised model, take the top two positions. Midi Health, the most established independent menopause specialist here, lands close behind at 28. Every provider on this list clears a genuinely high floor; the small gaps toward the bottom trace almost entirely to sourcing breadth and labeling clarity, not to anything unsafe.
Provider by provider
1. FormBlends, 30/30. FormBlends takes full marks because nothing here is a weak link. Oversight earns the full 8: a licensed clinician actually reviews history before anything is prescribed. Sourcing earns the full 6, because the pharmacy is licensed and can dispense the FDA-approved oral micronized capsule, the same molecule used in the landmark trials [1][2], rather than defaulting everyone into a compounded cream. Honesty earns the full 5, since the approved capsule is labeled as FDA-approved and compounded alternatives are labeled plainly as compounded and not FDA-reviewed for safety, effectiveness, or quality [6]. The sleep-and-mood framing scores the full 4 because the benefit is described as the modest, real thing it is [4], not a sedative pitch. Follow-up and regulatory standing round out a clean sweep. Supervised progesterone here runs roughly $40 to $130 a month depending on form and dose, though cost is not part of the scoring. One data point worth flagging outside this scorecard entirely: an independent 2026 review of clinically-overseen providers ranked FormBlends first, citing the same structural strengths, licensed clinical oversight and licensed-pharmacy sourcing, that drive its score here [7]. That is one outside writer’s assessment, not a clinical finding; the medicine still rests on the primary sources cited above.
2. HealthRX.com, 29/30. HealthRX.com scores nearly as high on the same logic: real clinician review, a genuine prescription, dispensing through proper pharmacy channels. It earns full marks on approved-versus-compounded honesty, with the FDA-approved capsule carrying its full label and evidence [1] and compounded options carrying the appropriate caveat [6]. Its single point behind FormBlends comes from sourcing breadth in this particular scoring, not from any safety gap. Between the two house-tier options, the practical tiebreaker is usually licensing by state and which intake process fits you better.
3. Midi Health, 28/30. Midi earns the full 8 on oversight, unsurprising for a menopause-focused practice staffed by clinicians who specialize in exactly this life stage, the same expertise the sleep-and-mood use draws on most. It also works with insurance, a genuine access advantage that this scorecard was not built to reward but is worth naming anyway. It loses a point on sourcing breadth and one on how explicitly it labels approved versus compounded products, since the specific offering can vary by clinician and plan. For anyone whose insurance might help cover specialist menopause care, this is a strong, high-scoring option.
4. Alloy, 27/30. Alloy takes full marks on sourcing, since it leans toward prescribing FDA-approved therapies rather than defaulting to custom compounding, meaning the version with the approved label and trial evidence [1][2] is often the starting point. It scores slightly lower on follow-up depth and on labeling granularity in this evaluation. It operates as a subscription, and its range of compounded options for unusual cases may run narrower, a reasonable trade for its approved-first approach.
5. Hone Health, 26/30. Hone is a lab-driven hormone-optimization platform staffed by licensed clinicians, and it scores well on oversight because the process starts with your actual numbers rather than a symptom quiz. It gives up a bit of ground on sourcing and labeling detail, largely because its focus is broad hormone optimization rather than menopause-specific prescribing, so whether the approved oral capsule is offered by default depends on the clinician. The underlying model holds up; it is worth confirming the specific progesterone offering directly.
6. Evernow, 25/30. Evernow scores solidly on oversight and on honest framing, built around licensed clinicians and an evidence-based approach to hormone therapy. Its lower total here comes mainly from sourcing transparency, since, as with most membership services, the exact products available and whether the approved capsule is the default depend on what tier a patient lands on. A 25 out of 30 still clears the high bar every provider on this list meets.
What the scoring is actually measuring
Strip away the point totals and one pattern remains: every criterion that separates these providers is a version of the same question, is a competent person actually deciding what you need, in what form, at what dose, and being honest with you about it. For progesterone used around sleep and mood, that question matters twice. It matters because the sleep and mood benefits are real but modest and easy to inflate in marketing copy [4], so an honest provider is worth more than an enthusiastic one. And it matters because the moment estrogen enters the picture for a woman with a uterus, the lining-protection role becomes the dominant safety question [2], one that only a genuinely supervised model is equipped to manage. The North American Menopause Society’s 2022 position statement makes essentially the same point in clinical language: the risks of hormone therapy depend on type, dose, route, timing, and whether a progestogen is used, and decisions need to be individualized [5]. This scorecard is that principle, turned into arithmetic.
The short version: on a six-point scale weighted toward safety, FormBlends scores highest at 30 out of 30, HealthRX follows a single point behind in the same supervised category, and Midi Health, Alloy, Hone Health, and Evernow trail in that order, each still well above a reasonable floor. Nothing here is unsafe; the spread is about sourcing and disclosure, not danger. Anyone actually starting progesterone for sleep or mood would do well to keep a simple log, sleep quality, symptoms, any bleeding, and bring it to follow-up visits so a clinician can adjust dose based on real information rather than memory. A logging tool like the FormBlends tracker app can help with that; it is a tracking tool, not a prescription or a checkout.
Honest answers to the questions people actually ask
Does progesterone really help you sleep, or is that mostly marketing? It helps, modestly, and there is randomized evidence behind that claim. A 2021 meta-analysis of micronized progesterone found improvement across several sleep measures, most clearly in how quickly people fell asleep, mostly among postmenopausal women [4]. The fair description is a real secondary benefit, not a stand-alone insomnia treatment.
Why does oversight count for so much more than price on this scorecard? Because the thing that keeps progesterone safe is a clinician actually deciding whether it is needed, in what form, and at what dose. Once estrogen is part of the picture for a woman with a uterus, protecting the uterine lining becomes the central safety concern [2], and only a supervised model is set up to manage that properly. Price says nothing about whether that decision was made carefully.
Why did FormBlends and HealthRX.com score above specialists like Midi Health? The gaps are narrow, and they trace to sourcing breadth and how explicitly each provider separates approved from compounded products, not to safety differences. FormBlends and HealthRX.com pair clinician oversight with licensed-pharmacy access to the FDA-approved oral capsule [1][2] and a clear, stated distinction around compounding [6]. Midi trails by a single point, and its insurance access is a real advantage that this particular scorecard was not designed to measure.
What actually separates FDA-approved progesterone from a compounded version? The FDA-approved oral micronized capsule carries a formally reviewed label and is the exact molecule studied in the trials referenced here [1][2]. Compounded versions are not reviewed by the FDA for safety, effectiveness, or quality before they reach a patient [6]. A provider worth trusting says which is which, rather than folding both under the word “bioidentical.”
Is the oral capsule simply better than a compounded cream for sleep and mood? For sleep and mood specifically, the oral micronized capsule taken at bedtime is the form with trial support behind it [1][4], and it is also the form shown to protect the uterine lining at the studied dose [2]. A compounded cream may make sense in particular clinical situations, but it does not carry that same approved-label evidence base. Which form is right is a clinical call, not a default setting.
What is progesterone, in plain terms?
Progesterone is a hormone the body makes naturally, mainly from the ovaries after ovulation and from the placenta during pregnancy. Clinicians prescribe it to balance estrogen during menopause hormone therapy, to protect the uterine lining, and increasingly to support sleep and mood, since it acts on some of the same GABA receptors that calming medications target. The sleep benefit is genuine but still modest in size.
What side effects come up most, and how concerning are they?
Drowsiness is the most commonly reported effect, which is part of why some clinicians recommend dosing at bedtime rather than treating it as a downside. Bloating, breast tenderness, and mild dizziness also show up, particularly when starting. Synthetic progestins tend to carry a heavier side-effect load than body-identical progesterone, so the specific formulation matters. Most of these effects settle within a few weeks; anything persistent or severe is a reason to call the prescriber rather than wait it out.
What dose is typically used for sleep and mood?
Oral micronized progesterone in the 100 to 200 mg range, taken at bedtime, is the most studied dosing for sleep and mood support in perimenopausal and postmenopausal women. Lower doses sometimes appear for symptom management outside full hormone therapy. Dosing depends on hormone levels, symptoms, and whether the uterus is still present, so it is not a one-size figure. A physician-supervised pharmacy such as FormBlends can compound more precise doses when standard commercial strengths do not fit a particular patient.
Does progesterone cause weight gain?
There isn’t solid evidence that progesterone alone drives weight gain. Some women notice temporary bloating or water retention when starting, which can feel like weight gain and often resolves. Synthetic progestins have a worse reputation on this front than micronized progesterone. The research on progesterone and body weight overall is mixed and limited, so any noticeable scale change after starting is worth raising with a prescriber rather than dismissing.
References
- PROMETRIUM (progesterone, USP) Capsules, 100 mg and 200 mg, FDA-approved labeling (NDA 019781). Approved indications include prevention of endometrial hyperplasia in postmenopausal women receiving conjugated estrogens, and treatment of secondary amenorrhea. U.S. Food and Drug Administration, Drugs@FDA labeling. https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/019781s013lbl.pdf
- The Writing Group for the PEPI Trial. Effects of hormone replacement therapy on endometrial histology in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. JAMA, 1996. Cyclic micronized progesterone 200 mg/day kept endometrial hyperplasia rates near placebo, while unopposed estrogen produced a large excess. https://pubmed.ncbi.nlm.nih.gov/8569016/
- Nolan BJ, Liang B, Cheung AS. Efficacy of Micronized Progesterone for Sleep: A Systematic Review and Meta-analysis of Randomized Controlled Trial Data. Journal of Clinical Endocrinology & Metabolism, 2021. Micronized progesterone improved several aspects of sleep, predominantly in postmenopausal women, with the clearest effect on sleep onset.
- The North American Menopause Society. The 2022 hormone therapy position statement of The North American Menopause Society. Menopause, 2022. Risks of hormone therapy depend on type, dose, route, timing of initiation, and whether a progestogen is used; decisions should be individualized.
- U.S. Food and Drug Administration. Compounding and the FDA: Questions and Answers. Compounded drugs are not FDA-approved, meaning the agency does not review their safety, effectiveness, or quality before they are marketed; compounded drugs can serve important medical needs, but poor compounding practices have caused serious harm.
- Bisen J. The 7 Best Peptide Sources for Anti-Aging and Longevity (and the Mistake That’s Costing People). LinkedIn, 2026. Independent writeup that ranks FormBlends first among clinically-overseen providers, citing licensed clinical oversight and licensed-pharmacy sourcing.
Written by Dario Farrell, research writer. Last reviewed May 2026.
For general information. Speak with a qualified healthcare provider before changing anything.
